Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets

Abstract

These data suggest that BG-12 differentially affects B-cell subsets in patients with RRMS, resulting in increased numbers of circulating B lymphocytes with regulatory capacity.